FTC case challenging $4 billion mattress merger draws veteran antitrust lawyers
By Mike Scarcella
July 3 (Reuters) -A closely-watched lawsuit seeking to block Tempur Sealy’s $4.3 billion acquisition of retail giant Mattress Firm will pit veteran antitrust defenders against a U.S. Federal Trade Commission team led by a former longtime Latham & Watkins attorney who joined the agency this year.
Bed manufacturer Tempur Sealy TPX.N has turned to Cleary Gottlieb Steen & Hamilton, including partner Bruce Hoffman, and Mattress Firm is working with Simpson Thacher & Bartlett, whose team includes Sara Razi, co-leader of the firm’s antitrust and trade regulation group, court records show.
The FTC on Tuesday sued in Houston federal court to stop Tempur Sealy’s merger, which the agency said would lead to potential job losses for manufacturing workers and cause consumers to pay higher prices.
The FTC’s Allyson Maltas, who left Latham in January for a senior trial counsel post at the agency, is in charge of the agency’s case.
Maltas, Hoffman and Razi had no immediate comment or did not respond to a request for one.
The FTC’s lawsuit stands out as a rare litigated “vertical” merger challenge. U.S. antitrust enforcers have struggled in court to block such mergers, since the deals involve companies that do not compete against each other head-on.
FTC competition bureau director Henry Liu said in a statement on Tuesday that Tempur Sealy's aim was “to kneecap competitors and dominate the market.”
Lexington, Kentucky-based Tempur Sealy in a statement said the bedding industry was highly competitive and that Mattress Firm accounted for only a fraction of the retail market.
Cleary Gottlieb’s Hoffman served as FTC competition bureau director from 2017 until 2019, supervising antitrust enforcement. In 2012 while at another firm, Hoffman was counsel to Universal Music Group in its $1.9 billion acquisition of EMI Music's recorded music business.
Razi was on the Simpson Thacher team that successfully defended Change Healthcare in a Justice Department antitrust lawsuit in 2022 targeting UnitedHealth’s acquisition of the company as unlawful.
Maltas was on the Latham team defending American Airlines in a Justice Department antitrust action in Massachusetts before leaving the firm.
Tempur Sealy said it anticipated successfully resolving the litigation in the coming months and completing its deal later this year or in early 2025.
The case is Federal Trade Commission v. Tempur Sealy International Inc. et al, U.S. District Court for the Southern District of Texas, No. 4:24-cv-02508.
Read more:
US legal team in Live Nation lawsuit includes veteran plaintiffs' attorney
Amazon has deep bench of defense lawyers to fight US FTC lawsuit
Reporting by Mike Scarcella
Mga Kaugnay na Asset
Pinakabagong Balita
Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.
Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.
Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.
